You may have heard of the weight loss drugs Ozempic or Wegovy. Investment Analyst Dr Deborah Lambie was on AM show on Three to discuss the rise of this new class of medicines called GLP-1’s and the potential impact they might have across the health system.
2024 © Milford Asset Management Limited Privacy Policy Terms & Conditions Disclosure Statement
Replacement Product Disclosure Statements are available here or on the relevant scheme’s offer register entry at the NZ Companies Office
Milford Funds Limited is the Manager and Issuer of the Milford KiwiSaver Plan and the Milford Investment Funds